Grazyna Brzezinska-Rajszys

Grazyna Brzezinska-Rajszys

Auto-generated profile, based on publicly available information

Grazyna Brzezinska-Rajszys

Department of Cardiology, The Children’s Memorial Health Institute, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2006 in JACC
Verified
Journal Article
Closed access
ATAphrodite Tzifa
Aphrodite Tzifa
PEPeter Ewert
Peter Ewert
GBGrazyna Brzezinska-Rajszys
Grazyna Brzezinska-Rajszys
BPBjoern Peters
Bjoern Peters
MZMaria Zubrzycka
Maria Zubrzycka
SQShakeel A. Qureshi
Shakeel A. Qureshi

1 November 1999 in Heart
Verified
Journal Article
Open access
PDF file
AMA G Magee
A G Magee
GBG Brzezinska-Rajszys
G Brzezinska-Rajszys
SQS A Qureshi
S A Qureshi
ERE Rosenthal
E Rosenthal
MZM Zubrzycka
M Zubrzycka
MTM Tynan
M Tynan
OBJECTIVE To determine the early results of balloon expandable stent implantation for aortic coarctation or recoarctation. DESIGN Prospective observational study. SETTING Two paediatric cardiology tertiary referral centres. PATIENTS 17 patients, median age 17 years (range 4.4 to 45) and median weight 61 kg (17 to 92). Six had native aortic coarctation and 11 had aortic recoarctation; 14 had upper limb systolic hypertension. Of those with recoarctation, eight had had at least one previous balloon dilatation attempt and two of these patients also had further surgical interventions. INTERVENTION Balloon expandable Palmaz iliac stent implantation. MAIN OUTCOME MEASURES Systolic pressures gradients, minimum aortic diameter, upper limb blood pressures, and incidence of aneurysm formation. RESULTS 18 stents were implanted during 18 procedures in the 17 patients. Mean peak systolic pressure gradient fell from 26 mm Hg (95% confidence interval (CI), 21 to 31 mm Hg) before to 5 mm Hg (2 to 8 mm Hg) after stent implantation (p < 0.001), and mean minimum aortic diameter increased from 7 mm (95% CI, 6 to 8 mm) before to 11.3 mm (10 to 12.6 mm) after implantation (p < 0.001). Complications occurred in five patients (bleeding in two, stent migration in two, and aneurysm formation in one). Two patients remained borderline hypertensive and eight were receiving antihypertensive treatment at most recent assessment. CONCLUSIONS Stent implantation for aortic recoarctation and native coarctation gives good immediate results. Careful follow up is necessary to evaluate complications and the long term effect on blood pressure.

3 January 2008 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
Lidia ZiolkowskaLidia Ziolkowska
Lidia Ziolkowska
WKWanda Kawalec
Wanda Kawalec
ATAnna Turska-Kmiec
Anna Turska-Kmiec
MKMałgorzata Krajewska-Walasek
Małgorzata Krajewska-Walasek
GBGrazyna Brzezinska-Rajszys
Grazyna Brzezinska-Rajszys
PBPiotr Burczynski
Piotr Burczynski

1 February 1999 in Heart
Verified
Journal Article
Open access
PDF file
GBG Brzezinska-Rajszys
G Brzezinska-Rajszys
SQS A Qureshi
S A Qureshi
JKJ Ksiazyk
J Ksiazyk
MZM Zubrzycka
M Zubrzycka
AKA Kosciesza
A Kosciesza
MTM Tynan
M Tynan
Objectives To determine outcome of stent implantation in patients with middle aortic syndrome. Design Prospective study, case series. Setting A tertiary paediatric cardiology centre in a children’s hospital. Patients Five patients, aged 4 to 17 years (mean 11.4 years), with upper limb hypertension due to middle aortic syndrome. Intervention Stents were implanted in the mid/lower thoracic/upper abdominal aorta. Main outcome measure Satisfactory deployment of stents and blood pressure control. Results In all patients, angiocardiography showed long segment stenosis in the mid or lower thoracic/upper abdominal aorta. The pressure gradient was between 40 and 90 mm Hg (mean 63.2 mm Hg). Seven Palmaz stents were implanted. Immediately after implantation, the gradient decreased to between 0 and 35 mm Hg (mean 13.6 mm Hg). Angiography showed a satisfactory result with widely patent stents in all. In one patient, thrombosis of the stent occurred six days after implantation. This was successfully treated with infusion of alteplase, further balloon dilatation, and implantation of a second stent overlapping the first, both dilated to 10 mm diameter. One patient had elective redilatation of the stent six months after implantation, with further reduction of the gradient from 35 mm Hg to 10 mm Hg. At the latest follow up between three and 20 months (mean 12.2 months) after stent implantation, in four patients blood pressure was better controlled with antihypertensive drugs. One patient was normotensive without drugs. Computed tomography showed no aneurysm formation in the region of the stents. Conclusions Stent implantation is a preferable alternative to surgery in the treatment of patients with middle aortic syndrome and merits further evaluation.

1 January 2000 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
BRBlair V. Robinson
Blair V. Robinson
GBGrazyna Brzezinska-Rajszys
Grazyna Brzezinska-Rajszys
HWHoward S. Weber
Howard S. Weber
JKJoanna Ksiazyk
Joanna Ksiazyk
FFF. Jay Fricker
F. Jay Fricker
JEJosé A. Ettedgui
José A. Ettedgui
Objectives: The purpose of this study was to evaluate the short and intermediate term results of infants who have undergone balloon aortic valvotomy from the carotid arterial approach, and to identify risk factors in those infants who had a poor outcome.Methods: Between 1988 and 1999, balloon aortic valvotomy was attempted at four centres in 95 infants with severe aortic stenosis. Echocardiographic and hemodynamic data, and outcome, were analysed retrospectively.Results: Valvotomy was accomplished in 92 of the 95 infants, with a median age of 5 days, a range from 0 to 191 days, and weighing 3.4 kg, with a range from 1.0 to 6.5 kg. Major procedural complications occurred in 10 infants. Post-procedural aortic regurgitation was severe in 5 patients. There were 13 early deaths, and 4 late deaths. The period of mean follow-up has been 2.1 years, with a range from 0 to 9.3 years. The actuarial survival at 3 years was 76 ± 6%. Further interventions were needed in 19 patients, giving a 3-year freedom from reintervention of 67 ± 6%. The 51 infants who were duct-dependent were further analyzed, and found to have a higher mortality (38%) compared to those infants not dependent on the arterial duct (5%). Risk factors for a poor outcome in the duct-dependent infants were mitral stenosis (p<0.005), a left ventricle which did not form the cardiac apex (p<0.005), and an aortic valve with a diameter of less than 6 mm (p<0.05).Conclusions: This multi-centric registry shows good results in the intermediate term for treating infants with severe aortic valvar stenosis with balloon valvotomy through a carotid arterial cutdown. Infants dependent on prostaglandin had a worse outcome, especially if they had any of the identified risk factors.

1 February 2004 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
SQShakeel A Qureshi
Shakeel A Qureshi
MZMaria Zubrzycka
Maria Zubrzycka
GBGrazyna Brzezinska-Rajszys
Grazyna Brzezinska-Rajszys
AKAndrzej Kosciesza
Andrzej Kosciesza
JKJoanna Ksiazyk
Joanna Ksiazyk
We inserted covered Cheatham-Platinum stents in 4 patients, ranging in age from 12 to 19 years, who weighed between 45 and 94 kg. All the patients had aortic coarctation, with surgical repair having been attempted previously in one, and with balloon dilation having been performed as the primary treatment in two, resulting in formation of aneurysms. The fourth patient had not received any treatment. The gradients were reduced from 10 to 40 mmHg before insertion of the stent to 0 to 5 mmHg after stenting. No complications were encountered. All the patients are well at an interval of 3 to 14 months after stenting.